The heart of Triton fund IV company Bormioli Pharma can be summed up in four words: “Small part, Big Impact”. Since becoming a stand-alone company in November 2017, the company pinpointed this very concept that animates its behaviour every day.

Bormioli Pharma, a leading pharma primary packaging manufacturer, produces "small things"  – however, these small things have a “big impact” on people’s lives. This motto is also more than just a description of what the company does, it is an important part of the company’s culture. It means striving for perfection and continuous innovation, aware that every detail matters.  

“Small part, Big Impact” can also be seen in Bormioli Pharma’s new corporate design and is also reflected in the company’s five-year strategic plan.

BORMIOLI PHARMA